日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Preclinical Validation of [(177)Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials

CD44v6靶向放射性药物[(177)Lu]Lu-AKIR001的临床前验证，即将进入首次人体试验

期刊:
影响因子:
doi:10.2967/jnumed.125.270782
Mortensen, Anja C L; Mohajershojai, Tabassom; Gustafsson, Amanda; Berglund, Hanna; Selvaraju, Ram Kumar; Hofström, Camilla; Persson, Helena; Ohlin, Mats; Tran, Thuy A; Morén, Anton Forsberg; Ochniewicz, Piotr; Zedenius, Jan; Bernhardt, Peter; Frejd, Fredrik Y; Nestor, Marika
Human
T细胞
CD4
CD44
发表日期：2026
文献求助 收藏

Familial Aggregation of Primary Hyperparathyroidism and Malignancy-Nationwide Case-Control and Cohort Study

原发性甲状旁腺功能亢进症与恶性肿瘤的家族聚集性——全国病例对照和队列研究

期刊:Journal of the Endocrine Society
影响因子:3.1
doi:10.1210/jendso/bvaf152
Thorsteinsson, David; Granath, Fredrik; Bränström, Robert; Zedenius, Jan; Nilsson, Inga-Lena
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

CD44v6 expression in non-anaplastic thyroid carcinoma: characterization of candidates for targeted therapy.

CD44v6 在非间变性甲状腺癌中的表达：靶向治疗候选者的特征分析。

期刊:Thyroid Research
影响因子:1.8
doi:10.1186/s13044-025-00266-3
Stenman Adam, Nilsson Joachim N, Condello Vincenzo, L Mortensen Anja C, Nestor Marika, Zedenius Jan, Juhlin C Christofer
甲状腺癌
肿瘤
T细胞
CD4
CD44
发表日期：2025
文献求助 收藏

Distinguishing neuroendocrine tumor grade 3 from neuroendocrine carcinoma in gastroenteropancreatic high-grade neoplasms

区分胃肠胰高级别肿瘤中的3级神经内分泌肿瘤和神经内分泌癌

期刊:Endocrine Oncology
影响因子:
doi:10.1530/EO-25-0065
Ankers, Zandra; Hellgren, L Samuel; Stenman, Adam; Zedenius, Jan; Juhlin, C Christofer
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Catching the Silent Culprits: TERT Promoter Mutation Screening of Minimally Invasive Follicular and Oncocytic Thyroid Carcinoma in Clinical Practice

发现无声的罪魁祸首：临床实践中微浸润性滤泡性甲状腺癌和嗜酸性甲状腺癌的TERT启动子突变筛查

期刊:Endocrine Pathology
影响因子:14.7
doi:10.1007/s12022-024-09828-x
Hellgren, L Samuel; Stenman, Adam; Jatta, Kenbugul; Condello, Vincenzo; Larsson, Catharina; Zedenius, Jan; Juhlin, C Christofer
肿瘤
肿瘤免疫
甲状腺癌
免疫/内分泌
TERT
发表日期：2024
文献求助 收藏

Regional variations in the management of primary hyperparathyroidism in Sweden: population-based case-control study

瑞典原发性甲状旁腺功能亢进症治疗的区域差异：基于人群的病例对照研究

期刊:BJS Open
影响因子:4.5
doi:10.1093/bjsopen/zrad154
Thorsteinsson, David; Granath, Fredrik; Bränström, Robert; Koman, Anna; Zedenius, Jan; Nilsson, Inga-Lena
发表日期：2024
文献求助 收藏

Immunotherapy and Tyrosine Kinase Inhibitor as a Bridge to Surgery for Clear Cell Renal Cell Carcinoma Metastases to the Thyroid: A Case Report and Literature Review

免疫疗法和酪氨酸激酶抑制剂作为透明细胞肾细胞癌甲状腺转移手术的桥梁：病例报告及文献综述

期刊:Case Reports in Oncology
影响因子:0.7
doi:10.1159/000541329
Bränström, Robert; Zedenius, Jan; Shabo, Ivan; Lindskog, Magnus; Juhlin, C Christofer
肿瘤
肿瘤免疫
信号转导
肾癌
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

Distinguishing between thyroid and parathyroid nodules by ultrasound: a potential game-changer in clinical practice?

利用超声鉴别甲状腺结节和甲状旁腺结节：临床实践中潜在的变革性技术？

期刊:Lancet Regional Health-Europe
影响因子:13
doi:10.1016/j.lanepe.2023.100769
Juhlin, C Christofer; Zedenius, Jan
免疫/内分泌
发表日期：2023
文献求助 收藏

Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer

甲状腺球蛋白表达、Ki-67指数和淋巴结比率在乳头状甲状腺癌预后评估中的应用

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-27684-3
Lindfors, Helene; Karlsen, Marie; Karlton, Ellinor; Zedenius, Jan; Larsson, Catharina; Ihre Lundgren, Catharina; Juhlin, C Christofer; Shabo, Ivan
Ki-67
肿瘤
甲状腺癌
免疫/内分泌
肿瘤免疫
发表日期：2023
文献求助 收藏

Adrenal and periadrenal schwannoma: histological, molecular and clinical characterization of an institutional case series

肾上腺及肾上腺周围神经鞘瘤：机构病例系列的组织学、分子和临床特征

期刊:Endocrine
影响因子:2.9
doi:10.1007/s12020-023-03463-y
Stenman, Adam; Falhammar, Henrik; Zedenius, Jan; Juhlin, C Christofer
免疫/内分泌
发表日期：2023
文献求助 收藏